Who Owns INKT?

MiNK Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$11.81

+0.20 (+1.72%)

Market Cap

$55.3M

Shares Outstanding

4,965,858

Institutional Holders

16

Total Inst. Value

$682K

% of Float Held

4.9%

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1VANGUARD GROUP INC$205K23,744
2NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO$156K18
3JONES FINANCIAL COMPANIES LLLP$129K8,519
4GEODE CAPITAL MANAGEMENT, LLC$96K11,254
5BlackRock, Inc.$76K8,778
6WELLS FARGO & COMPANY/MN$7K848
7BANK OF AMERICA CORP /DE/$6K757
8UBS Group AG$2K284
9OSAIC HOLDINGS, INC.$2K238
10Tower Research Capital LLC (TRC)$1K172

Related Stocks

Frequently Asked Questions

How many institutional investors hold INKT?

As of Q1 2025, 16 institutional investors report holding INKT (MiNK Therapeutics, Inc.) in their 13F filings.

What percentage of MiNK Therapeutics, Inc. is owned by institutions?

Institutional investors hold approximately 4.9% of MiNK Therapeutics, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most INKT?

The largest institutional holder of INKT is VANGUARD GROUP INC with $205K in shares.

Are institutions buying or selling INKT?

This quarter, 16 institutions opened new positions in INKT and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.